Back to BANK OF MONTREAL /CAN/ BANK OF MONTREAL /CAN/

AMLXAMLX

Showing 7 of 10 quarters

Position history for BANK OF MONTREAL /CAN/BANK OF MONTREAL /CAN/'s holdings in AMYLYX PHARMACEUTICALS INC

No. Bank of Montreal exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 138,525 shares worth $1.7M. Bank of Montreal first reported AMLX in Q2 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$442,017

Total Shares Change

-143,512

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$14.11
0
2025-Q4
Decreased
138,525
-3.6%
$1.7M0.0%$12.00
0
2025-Q3
Increased
143,752
+0.2%
$2M0.0%$14.90
26
2025-Q2
Unchanged
143,512
0.0%
$919,9120.0%$6.33
0
2025-Q1
Unchanged
143,512
0.0%
$508,0320.0%$3.66
0
2024-Q4
Unchanged
143,512
0.0%
$542,4760.0%$3.84
0
2024-Q3
Increased
143,512
+36.4%
$442,0170.0%$3.08
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used